Recap: Vistagen Therapeutics Q3 Earnings
Recap: Vistagen Therapeutics Q3 Earnings
Vistagen Therapeutics (NASDAQ:VTGN) reported its Q3 earnings results on Tuesday, February 13, 2024 at 04:21 PM.
Vistagen Therapeutics（纳斯达克股票代码：VTGN）于2024年2月13日星期二下午4点21分公布了其第三季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Vistagen Therapeutics beat estimated earnings by 26.67%, reporting an EPS of $-0.22 versus an estimate of $-0.3.
Vistagen Therapeutics的收益比预期高出26.67％，每股收益为-0.22美元，而估计为-0.3美元。
Revenue was up $231 thousand from the same period last year.
收入比去年同期增长了23.1万美元。
Past Earnings Performance
过去的收益表现
Last quarter the company beat on EPS by $0.02 which was followed by a 11.07% drop in the share price the next day.
上个季度，该公司的每股收益超过0.02美元，随后第二天股价下跌了11.07％。
To track all earnings releases for Vistagen Therapeutics visit their earnings calendar here.
要追踪Vistagen Therapeutics发布的所有财报，请在此处访问他们的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。